Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Mayo Clinic
Summary
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
Description
The proposed biospecimen repository would be derived from patients diagnosed with ILD. This is to include 500 patients in the repository, with each patient contributing one blood sample. Patients with pneumonia and healthy patients will also be recruited as a control group.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia * Patients willing to provide written informed consent Exclusion Criteria: * Unwillingness/unable to give blood samples
Interventions
- OtherILD
100 cc of blood collected from a total of 250 ILD patients. This includes IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20)), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis
- OtherHealthy
100 cc of blood collected from a total of 25 healthy volunteers in order to compare with the ILD participants.
- OtherPneumonia
100 cc of blood collected from a total of 100 participants with a diagnosis of pneumonia in order to compare with the ILD participants.
Location
- Mayo ClinicRochester, Minnesota